CAICaris Life SciencesHealth Care
$29.70EarningsNov 4, 2026
1D—1W—1M—3M—1Y—
Market cap$8.4BCompany infoRevenue$989.6M52-wk range$15 – $33IndustryBiotechnologyWebsitecarislifesciences.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▼ −1.0% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E83.0×710
P / S8.5×1117
5
14
P / FCF57.4×910
EV / EBITDA46.3×68
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin69.7%8168
43%
70%
Operating margin15.5%4853
-30%
61%
Net margin10.6%4958
-68%
42%
ROE19.5%6471
-71%
20%
ROIC14.8%7267
-95%
15%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.665047
0.7
3.2
Net debt / EBITDA-2.3×9090
Current ratio5.539491
Interest coverage3.3×3229
Per shareTTM, with year-over-year change
Revenue / share$3.50▲ +85%
EPS (diluted)$0.36▲ +113%
FCF / share$0.52▲ +204%
Est. EPS growth (fwd)—